Evidence map›Paper›PMID 41093992›Full record

ArticleNature microbiology2025

The IFIT2-IFIT3 antiviral complex targets short 5' untranslated regions on viral mRNAs for translation inhibition.

Dustin R Glasner, Candace Todd, Brian Cook, Agustina D'Urso, Shivani Khosla, Elena Estrada, Jaxon D Wagner, Mason D Bartels, Chuan-Tien Hung, Pierce Ford and 14 more

Abstract read
In one paragraph

Article in Nature microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Dustin R GlasnerSchool of Biological Sciences, University of California, San Diego, CA, USA.
Candace ToddSchool of Biological Sciences, University of California, San Diego, CA, USA.
Brian CookDepartment of Chemistry and Biochemistry, University of California, San Diego, CA, USA.
Agustina D'UrsoSchool of Biological Sciences, University of California, San Diego, CA, USA.
Shivani KhoslaSchool of Biological Sciences, University of California, San Diego, CA, USA.
Elena EstradaSchool of Biological Sciences, University of California, San Diego, CA, USA.
Jaxon D WagnerSchool of Biological Sciences, University of California, San Diego, CA, USA.
Mason D BartelsTherapeutic Innovation Center, Baylor College of Medicine, Houston, TX, USA.
Chuan-Tien HungDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Pierce FordSchool of Biological Sciences, University of California, San Diego, CA, USA.
Jordan PrychSchool of Biological Sciences, University of California, San Diego, CA, USA.
Kathryn S HatchSchool of Biological Sciences, University of California, San Diego, CA, USA.
Brian A YeeDepartment of Cellular and Molecular Medicine, University of California, San Diego, CA, USA.
Kaori M EgoDepartment of Cellular and Molecular Medicine, University of California, San Diego, CA, USA.
Qishan LiangDepartment of Cellular and Molecular Medicine, University of California, San Diego, CA, USA.
Sarah R HollandSchool of Biological Sciences, University of California, San Diego, CA, USA.
James Brett CaseDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.ORCID http://orcid.org/0000-0001-7331-5511
Kevin D CorbettSchool of Biological Sciences, University of California, San Diego, CA, USA.ORCID http://orcid.org/0000-0001-5854-2388
Michael S DiamondDepartment of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA.
Benhur LeeDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0003-0760-1709
Gene W YeoDepartment of Cellular and Molecular Medicine, University of California, San Diego, CA, USA.
Mark A HerzikDepartment of Chemistry and Biochemistry, University of California, San Diego, CA, USA.
Eric L Van NostrandTherapeutic Innovation Center, Baylor College of Medicine, Houston, TX, USA.
Matthew D DaughertySchool of Biological Sciences, University of California, San Diego, CA, USA. mddaugherty@ucsd.edu.ORCID http://orcid.org/0000-0002-4879-9603

Funding

Functional RNA elements in the human genomeR01HG004659 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Kevin Daniel Corbett, Eugene Wei-Ming Yeo · 2008 to 2026
$12.4M
Pathways in Biological Sciences Training ProgramT32GM133351 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Matthew Daugherty, Randolph Y. Hampton · 2020 to 2026
$9.9M
Technology Development Coordinating CenterU24HG011735 · NHGRI · JACKSON LABORATORY · PI Mark D ADAMS · 2021 to 2026
$8.1M
A comprehensive binding and functional map of human RNA-binding proteinsU24HG009889 · NHGRI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI GRAVELEY, BRENTON R., YEO, EUGENE WEI-MING · 2022 to 2025
$5.5M
STAMP technology to enable single-cell and isoform-sensitive detection of RBP sitesR01HG011864 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YEO, EUGENE WEI-MING · 2021 to 2024
$4.0M
Pathogen-driven evolution of innate antiviral defense mechanismsR35GM133633 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Matthew Daugherty · 2019 to 2026
$3.3M
Molecular mechanisms of nucleic acid recognition and maintenance in meiosis and innate immunityR35GM144121 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Kevin Daniel Corbett · 2022 to 2026
$2.7M
Ribo-STAMPEDE: novel tools for molecular profiling of brain cell typesRF1MH126719 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI LIPPI, GIORDANO, YEO, EUGENE WEI-MING · 2022 to 2022
$2.3M
Understanding the Tropism and Pathogenesis of PararubulavirusesR37AI188431 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Benhur Lee, Jean Kyou Lim · 2025 to 2026
$1.6M
Robust, high-throughput identification of RNA processing regulators and regulatory networks genome-wideR00HG009530 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI VAN NOSTRAND, ERIC LYMAN · 2020 to 2022
$747k
Consequences of IFIT Gene Evolution on Species-Specific Antiviral ImmunityK22AI119017 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAUGHERTY, MATTHEW · 2016 to 2017
$267k
NHGRI NIH HHS R00 HG009530NHGRI NIH HHS R01 HG004659NHGRI NIH HHS R01 HG011864NHGRI NIH HHS U24 HG009889NHGRI NIH HHS U24 HG011735NIAID NIH HHS K22 AI119017NIAID NIH HHS R37 AI188431NIGMS NIH HHS R35 GM133633NIGMS NIH HHS R35 GM144121NIGMS NIH HHS T32 GM133351NIMH NIH HHS RF1 MH126719United States Department of Defense | Defense Advanced Research Projects Agency (DARPA) HR001124S0025-FP-005U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (NHGRI) HG011864U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01 AI188431
6 · The paper itself

Abstract

Recognition of foreign RNA is critical for the innate immune response to viruses. Interferon (IFN)-induced proteins with tetratricopeptide repeats (IFIT) 2 and 3 are highly upregulated following viral infection, but mechanistic insight into their antiviral role is lacking. Here we demonstrate that short 5' untranslated regions (UTRs), a characteristic of many viral mRNAs, can serve as a molecular pattern for innate immune recognition via IFIT2 and IFIT3. Structure determination of the IFIT2-IFIT3 complex at 3.2 Å using cryo-EM reveals a domain-swapped heterodimer that is required for recognition of the viral mRNA 5' end, translation inhibition and antiviral activity. Critically, viral or host 5' UTR lengths less than 50 nucleotides are necessary and sufficient to enable translation inhibition by the IFIT2-IFIT3 complex. Accordingly, diverse viruses whose mRNAs contain short 5' UTRs, such as vesicular stomatitis virus and parainfluenza virus 3, are sensitive to IFIT2-IFIT3-mediated antiviral activity. Our work thus reveals a pattern of antiviral nucleic acid immune recognition that takes advantage of the inherent constraints on viral genome size.

Indexed as

5' Untranslated RegionsCarrier ProteinsIntracellular Signaling Peptides and ProteinsProtein BiosynthesisRNA-Binding ProteinsRNA, MessengerRNA, ViralApoptosis Regulatory ProteinsCryoelectron MicroscopyHEK293 CellsHumansImmunity, Innate5' Untranslated RegionsApoptosis Regulatory ProteinsCarrier ProteinsIFIT2 protein, humanIFIT3 protein, humanIntracellular Signaling Peptides and ProteinsRNA-Binding ProteinsRNA, MessengerRNA, Viral

Identifiers

PMID41093992
PMCPMC12570964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.